Trademark Overview
On Monday, January 26, 2026, a trademark application was filed for BIOREGENIX with the United States Patent and Trademark Office. The USPTO has given the BIOREGENIX trademark a serial number of 99614217. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, January 26, 2026. This trademark is owned by TruHlth Holdings Inc.. The BIOREGENIX trademark is filed in the Pharmaceutical Products category with the following description:
Topical analgesic creams; Medicinal preparations for promoting rapid soft tissue regeneration and repair; Medicinal preparations for stimulating cellular activity at the molecular level, accelerating the healing process for soft tissue injuries, including aches, sprains, strains, and performance and age-related muscle pain